Russia To Finish Post-Registration Trials Of EpiVacCorona Vaccine In Summer End- Developer
Umer Jamshaid Published April 08, 2021 | 11:50 AM
MOSCOW (UrduPoint News / Sputnik - 08th April, 2021) Post-registration trials of Russia's EpiVacCorona vaccine against the coronavirus are scheduled to be completed in the end of the summer, Rinat Maksyutov, the director of the Vector research center that developed the vaccine, said in an interview with Sputnik.
"In the end of the summer 2021," Maksyutov said.
EpiVacCorona became Russia's second registered vaccine against COVID-19 in October 2020.
Recent Stories
Naqvi directs foolproof measures for protection of Chinese nationals
7 minutes ago
Israel carries out attack inside Iran, report US media
3 hours ago
Saudi Assistant Minister of Defence calls on army chief
3 hours ago
Currency Rate In Pakistan - Dollar, Euro, Pound, Riyal Rates On 19 April 2024
6 hours ago
Today Gold Rate in Pakistan 19 April 2024
7 hours ago
Rock-solid Ruud racks up season-leading win in Barcelona
15 hours ago
At UN, Iran says it will make Israel 'regret' reprisals
15 hours ago
G7 hears calls for 'critical' Ukraine aid
15 hours ago
EU seeks to leverage might to confront China, US challenge
15 hours ago
5 Customs officials martyred as their vehicle ambushed by terrorists in D I Khan
16 hours ago
Pak-New Zealand match called off due to rain
16 hours ago
NHA restores traffic on roads affected by recent rains in Balochistan
16 hours ago